1. Scrip

Heptares-Powered Sosei's Incoming CEO Explains What Happens Next

 
• By Sukaina Virji

Japanese company Sosei conducted a master stroke last year when it acquired UK biotechnology company Heptares as its in-house R&D engine. Deal after quality deal has ensued, and Sosei's share price has rocketed by more than 400%. Scrip's Sukaina Virji spoke to Sosei's COO – and CEO-elect – Peter Bains to find out what happens next.

After almost six years as a non-executive member of Sosei Group Corp.'s board and one of the key architects of Sosei's long-term strategic vision, Peter Bains was appointed Sosei's COO at the start of April. If all goes to plan, he will take over the CEO role from company founder and chair Shinichi Tamura at the AGM in June this year.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Japan

More from Focus On Asia